Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging
Open accessAbstract
OBJECTIVE: Ferumoxytol, an ultrasmall superparamagnetic iron oxide particle, has been suggested as a potential alternative MRI contrast agent in patients with renal failure. We compared ferumoxytol to gadoteridol enhancement on T1- and T2-weighted MRI in CNS disorders to explore its diagnostic utility. SUBJECTS AND METHODS: Data were collected from three protocols in 70 adults who underwent alternate-day gadoteridol- and ferumoxytol-enhanced MRI using identical parameters. Two neuroradiologists measured lesion-enhancing size and intensity on contrast-enhanced T1-weighted images in consensus. T2-weighted images were evaluated for the presence of contrast-enhanced hypointensity. Mixed model repeated measures analysis of variance determined differences between T1-weighted enhancement size and intensity for individual protocols and group. RESULTS: After exclusions, 49 MRI studies in 29 men and 20 women (mean age, 51 years) were assessed. T1-weighted estimated enhancing sizes were different between agents (p = 0.0456) as a group; however, no differences were observed with untreated gliomas (n = 17) in two protocols (p = 1.0 and p = 0.99, respectively). Differences in T1-weighted enhancement intensity between agents were significant for the group overall (p = 0.0006); however, three-way interactions were not significant (p = 0.1233). T2-weighted images were assessed for contrast-enhanced hypointensity, observed in 26 of 49 (53%) ferumoxytol and zero of 49 (0%) gadoteridol scans. CONCLUSION: Ferumoxytol may be a useful MRI contrast agent in patients who are unable to receive gadolinium-based contrast agents. Greater experience with a wider variety of disorders is necessary to understand differences in enhancement with ferumoxytol compared with gadolinium-based contrast agents, given their different mechanisms of action.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Ferumoxytol did not show superiority over gadolinium-based agents for detecting brain cancer lesions with contrast-enhanced MRI.
“In general, ferumoxytol did not show superiority over gadolinium-based agents for detecting brain cancer lesions with contrast-enhanced MRI [190].”
From Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications (2019) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Weinstein, J. S., Varallyay, C. G., Dosa, E., Gahramanov, S., Hamilton, B., Rooney, W. D., Muldoon, L. L., & Neuwelt, E. A. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.192 · Cited by 500 · see citing works
Self-citationBourrinet, P., Bengele, H. H., Bonnemain, B., Dencausse, A., Idée, J., Jacobs, P. M., & Lewis, J. M. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000197669.80475.dd · Cited by 335 · see citing works
Neuwelt, E. A., Hamilton, B. E., Varallyay, C. G., Rooney, W. R., Edelman, R. D., Jacobs, P. M., & Watnick, S. G. (2009) · Kidney International · doi:10.1038/ki.2008.496 · Cited by 267 · see citing works
Neuwelt, E. A., Várallyay, P., Bagó, A. G., Muldoon, L. L., Nesbit, G. M., & Nixon, R. A. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00557.x · Cited by 218 · see citing works
Self-citationNeuwelt, E. A., Várallyay, C. G., Manninger, S., Solymosi, D., Haluska, M., Hunt, M. A., Nesbit, G., Stevens, A., Jerosch-Herold, M., Jacobs, P. M., et al. (2007) · Neurosurgery · doi:10.1227/01.neu.0000255350.71700.37 · Cited by 184 · see citing works
Self-citationDetection and quantification of magnetically labeled cells by cellular MRI
Liu, W., & Frank, J. A. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.09.021 · Cited by 177 · see citing works
Morishige, K., Kacher, D. F., Libby, P., Josephson, L., Ganz, P., Weissleder, R., & Aikawa, M. (2010) · Circulation · doi:10.1161/circulationaha.109.891804 · Cited by 168 · see citing works
Gahramanov, S., Raslan, A. M., Muldoon, L. L., Hamilton, B. E., Rooney, W. D., Várallyay, C. G., Njus, J. M., Haluska, M., & Neuwelt, E. A. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.10.072 · Cited by 151 · see citing works
Self-citationVárallyay, P., Nesbit, G. M., Muldoon, L. L., Nixon, R. R., Delashaw, J. B., Cohen, J. I., Petrillo, A., Rink, D., & Neuwelt, E. A. (2002) · PubMed Central · Cited by 149 · see citing works
Self-citationLim, J. H., Choi, D., Cho, S. K., Kim, S. H., Lee, W. J., Lim, H. K., Park, C. K., Paik, S. W., & Kim, Y. I. (2001) · Radiology · doi:10.1148/radiol.2203001777 · Cited by 108 · see citing works
Kuo, K., Hung, S., Wei, Y., & Tarng, D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101084 · Cited by 95 · see citing works
Ferumoxytol in clinical practice: Implications for MRI
McCullough, B. J., Kolokythas, O., Maki, J. H., & Green, D. E. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23879 · Cited by 72 · see citing works
Christen, T., Ni, W. W., Qiu, D., Schmiedeskamp, H., Bammer, R., Moseley, M. E., & Zaharchuk, G. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24500 · Cited by 61 · see citing works
Hasan, D. M., Amans, M. R., Tihan, T., Hess, C. P., Guo, Y., Cha, S., Su, H., Martin, A. J., Lawton, M. T., Neuwelt, E. A., et al. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0172-y · Cited by 57 · see citing works
Self-citationDósa, E., Guillaume, D. J., Haluska, M., Lacy, C., Hamilton, B. E., Njus, J. M., Rooney, W. D., Kraemer, D. F., Muldoon, L. L., & Neuwelt, E. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq172 · Cited by 55 · see citing works
Self-citationHunt, M. A., Bagó, A. G., & Neuwelt, E. A. (2005) · PubMed · Cited by 48 · see citing works
Self-citationDual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors
Thompson, E. M., Guillaume, D. J., Dósa, E., Li, X., Nazemi, K. J., Gahramanov, S., Hamilton, B. E., & Neuwelt, E. A. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0872-x · Cited by 41 · see citing works
Self-citationDadashzadeh, E. R., Hobson, M. J., Bryant, L. H., Dean, D. D., & Frank, J. A. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1493 · Cited by 39 · see citing works
Muldoon, L. L., Tratnyek, P. G., Jacobs, P. M., Doolittle, N. D., Christoforidis, G. A., Frank, J. A., Lindau, M., Lockman, P. R., Manninger, S., Qiang, Y., et al. (2006) · PubMed Central · Cited by 28 · see citing works
Self-citationHAM56-Immunoreactive Macrophages in Untreated Infiltrating Gliomas
Cummings, T. J., Hulette, C. M., Bigner, S. H., Riggins, G. J., & McLendon, R. E. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0637-himiui · Cited by 18 · see citing works
Hövels, A. M., Heesakkers, R. A. M., Adang, E., Barentsz, J. O., Jager, G. J., & Severens, J. L. (2009) · Radiology · doi:10.1148/radiol.2531071360 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,076 · see citing works
Akers, A. L., Salman, R. A., Awad, I. A., Dahlem, K., Flemming, K. D., Hart, B. L., Kim, H., Jusué-Torres, I., Kondziolka, D. S., Lee, C., et al. (2017) · Neurosurgery · doi:10.1093/neuros/nyx091 · Cited by 498 · see citing works
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y., Dong, Z., Wang, S., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramı́rez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 456 · see citing works
Emerging applications for ferumoxytol as a contrast agent in MRI
Bashir, M. R., Bhatti, L., Marin, D., & Nelson, R. C. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24691 · Cited by 373 · see citing works
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging
Toth, G. B., Varallyay, C. G., Horvath, A., Bashir, M. R., Choyke, P. L., Daldrup-Link, H. E., Dosa, E., Finn, J. P., Gahramanov, S., Harisinghani, M., et al. (2017) · Kidney International · doi:10.1016/j.kint.2016.12.037 · Cited by 317 · see citing works
Self-citationSafety and technique of ferumoxytol administration for MRI
Vasanawala, S. S., Nguyen, K., Hope, M. D., Bridges, M. D., Hope, T. A., Reeder, S. B., & Bashir, M. R. (2016) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26151 · Cited by 210 · see citing works
Ramanathan, R. K., Korn, R. L., Raghunand, N., Sachdev, J. C., Newbold, R. G., Jameson, G., Fetterly, G. J., Prey, J., Klinz, S. G., Kim, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1990 · Cited by 183 · see citing works
Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside
Liu, H., Zhang, J., Chen, X., Du, X., Zhang, J., Liu, G., & Zhang, W. (2016) · Nanoscale · doi:10.1039/c6nr00147e · Cited by 120 · see citing works
External stimulus responsive inorganic nanomaterials for cancer theranostics
Mohamed, M. S., Veeranarayanan, S., Maekawa, T., & Sakthi Kumar, D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.007 · Cited by 114 · see citing works
Lapusan, R., Borlan, R., & Focşan, M. (2024) · Nanoscale Advances · doi:10.1039/d3na01064c · Cited by 107 · see citing works
Várallyay, C. G., Nesbit, E. G., Fu, R. F., Gahramanov, S., Moloney, B., Earl, E., Muldoon, L. L., Li, X., Rooney, W. D., & Neuwelt, E. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.36 · Cited by 104 · see citing works
Self-citationClinical Trials of Thermosensitive Nanomaterials: An Overview
Nardecchia, S., Sánchez‐Moreno, P., de Vicente, J., Marchal, J. A., & Boulaiz, H. (2019) · Nanomaterials · doi:10.3390/nano9020191 · Cited by 100 · see citing works
Delivery of Chemotherapeutics Across the Blood–Brain Barrier
Doolittle, N. D., Muldoon, L. L., Culp, A. Y., & Neuwelt, E. A. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.002 · Cited by 97 · see citing works
Self-citationFerumoxytol in clinical practice: Implications for MRI
McCullough, B. J., Kolokythas, O., Maki, J. H., & Green, D. E. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23879 · Cited by 72 · see citing works
Iron Oxide as an Mri Contrast Agent for Cell Tracking: Supplementary Issue
Korchinski, D. J., Taha, M., Yang, R., Nathoo, N., & Dunn, J. F. (2015) · Magnetic Resonance Insights · doi:10.4137/mri.s23557 · Cited by 73 · see citing works
Iron Administration before Stem Cell Harvest Enables MR Imaging Tracking after Transplantation
Khurana, A., Chapelin, F., Beck, G., Lenkov, O. D., Donig, J., Nejadnik, H., Messing, S., Derugin, N., Chan, R. C., Gaur, A., et al. (2013) · Radiology · doi:10.1148/radiol.13130858 · Cited by 68 · see citing works
Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL
Farrell, B. T., Hamilton, B. E., Dósa, E., Rimely, E., Nasseri, M. N., Gahramanov, S., Lacy, C. A., Frenkel, E. P., Doolittle, N. D., Jacobs, P. M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31829bfd8f · Cited by 67 · see citing works
Self-citationChristen, T., Ni, W. W., Qiu, D., Schmiedeskamp, H., Bammer, R., Moseley, M. E., & Zaharchuk, G. (2012) · Magnetic Resonance in Medicine · doi:10.1002/mrm.24500 · Cited by 61 · see citing works
Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children
Ruangwattanapaisarn, N., Hsiao, A., & Vasanawala, S. S. (2014) · Pediatric Radiology · doi:10.1007/s00247-014-3226-3 · Cited by 61 · see citing works
Hasan, D. M., Amans, M. R., Tihan, T., Hess, C. P., Guo, Y., Cha, S., Su, H., Martin, A. J., Lawton, M. T., Neuwelt, E. A., et al. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0172-y · Cited by 57 · see citing works
Self-citationRenal Transplant Imaging Using Magnetic Resonance Angiography With a Nonnephrotoxic Contrast Agent
Bashir, M. R., Jaffe, T. A., Brennan, T. V., Patel, U. D., & Ellis, M. J. (2013) · Transplantation · doi:10.1097/tp.0b013e318295464c · Cited by 54 · see citing works
Bashir, M. R., Mody, R. N., Neville, A. M., Javan, R., Seaman, D. M., Kim, C., Gupta, R. T., & Jaffe, T. A. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24330 · Cited by 52 · see citing works
Yuan, H., Wilks, M. Q., Normandin, M. D., Fakhri, G. E., Kaittanis, C., & Josephson, L. (2018) · Nature Protocols · doi:10.1038/nprot.2017.133 · Cited by 52 · see citing works
Liu, L., Tseng, L., Ye, Q., Wu, Y. L., Bain, D. J., & Ho, C. (2016) · Scientific Reports · doi:10.1038/srep26271 · Cited by 51 · see citing works
MRI with ferumoxytol: A single center experience of safety across the age spectrum
Nguyen, K., Yoshida, T., Han, F., Ayad, I., Reemtsen, B. L., Salusky, I. B., Satou, G. M., Hu, P., & Finn, J. P. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25412 · Cited by 51 · see citing works
What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent
Várallyay, C. G., Tóth, G. B., Fu, R. F., Netto, J. P., Firkins, J. L., Ambady, P., & Neuwelt, E. A. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5188 · Cited by 51 · see citing works
Self-citationFerumoxytol nanoparticle uptake in brain during acute neuroinflammation is cell-specific
McConnell, H., Schwartz, D. L., Richardson, B. E., Woltjer, R. L., Muldoon, L. L., & Neuwelt, E. A. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.03.009 · Cited by 50 · see citing works
Self-citationUSPIO‐Enhanced MRI Neuroimaging: A Review
Gkagkanasiou, M., Ploussi, A., Gazouli, M., & EFSTATHOPOULOS, E. P. (2015) · Journal of Neuroimaging · doi:10.1111/jon.12318 · Cited by 49 · see citing works
Positive magnetic resonance angiography using ultrafine ferritin-based iron oxide nanoparticles
Cai, Y., Wang, Y., Xu, H., Cao, C., Zhu, R., Tang, X., Zhang, T., & Pan, Y. (2018) · Nanoscale · doi:10.1039/c8nr06812g · Cited by 43 · see citing works
Finn, J. P., Nguyen, K., & Hu, P. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25580 · Cited by 42 · see citing works
Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors
Thompson, E. M., Guillaume, D. J., Dósa, E., Li, X., Nazemi, K. J., Gahramanov, S., Hamilton, B. E., & Neuwelt, E. A. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0872-x · Cited by 41 · see citing works
Self-citationDadashzadeh, E. R., Hobson, M. J., Bryant, L. H., Dean, D. D., & Frank, J. A. (2012) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1493 · Cited by 39 · see citing works
The art of attraction: applications of multifunctional magnetic nanomaterials for malignant glioma
Wegscheid, M. L., Morshed, R. A., Cheng, Y., & Lesniak, M. S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.912629 · Cited by 30 · see citing works
Li, Y., Xie, M., Jones, J. B., Zhang, Z., Wang, Z., Dang, M. T., Wang, X., Lipowska, M., & Mao, H. Z. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102816 · Cited by 30 · see citing works
Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations
Fares, J., Kanojia, D., Rashidi, A., Ahmed, A. U., Balyasnikova, I. V., & Lesniak, M. S. (2019) · Clinical Breast Cancer · doi:10.1016/j.clbc.2019.05.018 · Cited by 27 · see citing works
Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses
Shi, Q., Pisani, L. J., Lee, Y. K., Messing, S., Ansari, C., Bhaumik, S., Lowery, L., Lee, B. D., Meyer, D. E., & Daldrup-Link, H. E. (2013) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1526 · Cited by 26 · see citing works
Khandhar, A. P., Wilson, G. J., Kaul, M. G., Salamon, J., Jung, C., & Krishnan, K. M. (2018) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36438 · Cited by 20 · see citing works
Data collection and analysis strategies for phMRI
Mandeville, J. B., Liu, C. H., Vanduffel, W., Marota, J. J. A., & Jenkins, B. G. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.02.018 · Cited by 19 · see citing works
Magnetic Resonance Contrast Agents for Liver Imaging
Bashir, M. R. (2014) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2014.04.002 · Cited by 19 · see citing works
High-field small animal magnetic resonance oncology studies
Bokacheva, L., Ackerstaff, E., Lekaye, C., Zakian, K. L., & Koutcher, J. A. (2013) · Physics in Medicine and Biology · doi:10.1088/0031-9155/59/2/r65 · Cited by 15 · see citing works
Kersch, C. N., Ambady, P., Hamilton, B. E., & Barajas, R. F. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.21.26159 · Cited by 13 · see citing works
Self-citationA Chelate-Free Nano-Platform for Incorporation of Diagnostic and Therapeutic Isotopes
Gholami, Y. H., Josephson, L., Akam, E. A., Caravan, P. D., Wilks, M. Q., Pan, X.-Z., Maschmeyer, R. T., Kolnick, A. L., Fakhri, G. E., Normandin, M. D., et al. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s227931 · Cited by 12 · see citing works
Dodo, T., Okada, T., Yamamoto, A., Kanagaki, M., Fushimi, Y., Okada, T., Sakata, A., Arakawa, Y., Miyamoto, S., & Togashi, K. (2016) · Clinical Imaging · doi:10.1016/j.clinimag.2016.08.016 · Cited by 12 · see citing works
Incidental ferumoxytol artifacts in clinical brain MR imaging
Bowser, B. A., Campeau, N. G., Carr, C. M., Diehn, F. E., McDonald, J. S., Miller, G. M., & Kaufmann, T. J. (2016) · Neuroradiology · doi:10.1007/s00234-016-1747-1 · Cited by 12 · see citing works
A methotrexate labelled dual metal oxide nanocomposite for long-lasting anti-cancer theranostics
Tang, J., Moonshi, S. S., Wu, Y., Cowin, G., Vazquez‐Prada, K. X., Nguyen, D. H. T., Bulmer, A. C., & Ta, H. T. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101377 · Cited by 11 · see citing works
Park, E., Lee, W., So, Y. H., Lee, Y., Jeon, B.-S., Choi, K. S., Kim, E., & Myeong, W.-J. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000321 · Cited by 10 · see citing works
The Long-Lasting Effect of Ferumoxytol on Abdominal Magnetic Resonance Imaging
Harman, A. L., Chang, K. J., Dupuy, D. E., & Rintels, P. B. (2014) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000086 · Cited by 8 · see citing works
Horváth, A., Várallyay, C. G., Schwartz, D., Tóth, G. B., Netto, J. P., Barajas, R., Várallyay, P., Szidonya, L. K., Firkins, J. L., Youngers, E. H., et al. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27028 · Cited by 8 · see citing works
Self-citationSuperiority of Ferumoxytol MRI over Precontrast Imaging in Patients with Malignant Brain Lesions
Strauss, W., Fu, R. F., Szidonya, L. K., Muir, L., Huddleston, A. E., Branton, D., & Neuwelt, E. A. (2026) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9172 · Cited by 7 · see citing works
Self-citationDósa, E. (2013) · Cited by 7 · see citing works
Durighel, G., Tokarczuk, P. F., Karsa, A., Gordon, F., Cook, S. A., & O’Regan, D. P. (2016) · Clinical Radiology · doi:10.1016/j.crad.2015.12.008 · Cited by 6 · see citing works
Nitrite induces the extravasation of iron oxide nanoparticles in hypoxic tumor tissue
Mistry, N. N., Stokes, A. M., Gambrell, J. V., & Quarles, C. C. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3078 · Cited by 4 · see citing works
MRI assessment of experimental gliomas using 17.6 T
Schwarz, M. A., Pham, M., Helluy, X., Doerfler, A., & Engelhorn, T. (2013) · Neuroradiology · doi:10.1007/s00234-013-1149-6 · Cited by 4 · see citing works
Kirichenko, A., Lee, D., Wagner, P. L., Oh, S., Lee, H. J., Pavord, D., Shamsesfandabadi, P., Chen, A. M., Machado, L., Bunker, M. L., et al. (2025) · Cancers · doi:10.3390/cancers17071088 · Cited by 3 · see citing works
Владимирович, Ш. Е., Sannikov, A. B., Emelyanenko, V. M., Kryukova, L. N., Baranova, A. E., & Rachkov, M. A. (2021) · Medical Visualization · doi:10.24835/1607-0763-901 · Cited by 3 · see citing works
Automatic design and optimization of MRI-based neurochemical sensors via reinforcement learning
Ali, Z., Asparin, A., Zhang, Y., Mettee, H., Taha, D., Ha, Y., Bhanot, D., Sarwar, K., Kiran, H., Wu, S., et al. (2025) · Discover Nano · doi:10.1186/s11671-025-04338-z · Cited by 1 · see citing works
González, C. C., & Valverde, P. O. (2025) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575400653251008064030 · Cited by 1 · see citing works
Quantitative magnetic resonance imaging with magnetic nanoparticles
Gharagouzloo, C. A. (2016) · doi:10.17760/d20211451
Golovko, D. M., Khan, R., & Daldrup-Link, H. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781107360044.015
Imaging of Central Nervous System Tumors
Ly, I., Albert, N. L., & Gerstner, E. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-04152-6_3
Real-world evidence on gadoteridol safety
Chang, Y., Yao, L., Zhang, H., Chen, H., Liu, S., & Nie, M. (2026) · Medicine · doi:10.1097/md.0000000000050894
- Authors
- Hamilton, B. E., Nesbit, G. M., Dosa, E., Gahramanov, S., Rooney, B., Nesbit, E. G., Raines, J., & Neuwelt, E. A.
- Affiliations
- Oregon Health & Science University (US)
- Department of Neurology, Oregon Health and Science University, Portland, OR.
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 2011-10
- Volume
- 197
- Issue
- 4
- Pages
- 981-988
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- PMC
- PMC3412424
- OpenAlex
- W2014291850
- Cited by
- 63
- References
- 21
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 10 · 2015: 2 · 2014: 8 · 2013: 9 · 2012: 5
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Roentgenology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA137488, R01CA137488)
- National Institute of Neurological Disorders and Stroke (R01NS053468, R37NS044687, R01NS044687, NS53468, NS-44687)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Materials Science › Materials Chemistry › Lanthanide and Transition Metal Complexes
- Physical Sciences › Engineering › Biomedical Engineering › Characterization and Applications of Magnetic Nanoparticles
- Keywords
- ferumoxytol, gadoteridol, MRI contrast agents, superparamagnetic iron oxide nanoparticles, gadolinium-based contrast agents, T2 hypointensity, glioma, renal failure, central nervous system disorders, contrast-enhanced MRI
- MeSH terms
- Analysis of Variance, Brain Neoplasms, Contrast Media, Female, Gadolinium, Heterocyclic Compounds, Humans, Image Enhancement, Image Interpretation, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Organometallic Compounds, Least-Squares Analysis, Ferrosoferric Oxide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
